The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study
The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study
Background: In 2014 approximately 21,200 patients were diagnosed with oesophageal and gastric cancer in England and Wales, of whom 37 % underwent planned curative treatments. Potentially curative surgical resection is associated with significant morbidity and mortality. For operable locally advanced disease, neoadjuvant chemotherapy (NAC) improves survival over surgery alone. However, NAC carries the risk of toxicity and is associated with a decrease in physical fitness, which may in turn influence subsequent clinical outcome. Lower levels of physical fitness are associated with worse outcome following major surgery in general and Upper Gastrointestinal Surgery (UGI) surgery in particular. Cardiopulmonary exercise testing (CPET) provides an objective assessment of physical fitness. The aim of this study is to test the hypothesis that NAC prior to upper gastrointestinal cancer surgery is associated with a decrease in physical fitness and that the magnitude of the change in physical fitness will predict mortality 1 year following surgery.
Methods: This study is a multi-centre, prospective, blinded, observational cohort study of participants with oesophageal and gastric cancer scheduled for neoadjuvant cancer treatment (chemo- and chemoradiotherapy) and surgery. The primary endpoints are physical fitness (oxygen uptake at lactate threshold measured using CPET) and 1-year mortality following surgery; secondary endpoints include post-operative morbidity (Post-Operative Morbidity Survey (POMS)) 5 days after surgery and patient related quality of life (EQ-5D-5 L).
Discussion: The principal benefits of this study, if the underlying hypothesis is correct, will be to facilitate better selection of treatments (e.g. NAC, Surgery) in patients with oesophageal or gastric cancer. It may also be possible to develop new treatments to reduce the effects of neoadjuvant cancer treatment on physical fitness. These results will contribute to the design of a large, multi-centre trial to determine whether an in-hospital exercise-training programme that increases physical fitness leads to improved overall survival.
1-8
West, M.A.
98b67e58-9875-4133-b236-8a10a0a12c04
Loughney, L.
9c3e7db1-468b-405c-b32f-cedd9cc251fe
Ambler, G.
c4c7c8c3-b1f3-4407-86ee-efe7952d8307
Dimitrov, B.D.
366d715f-ffd9-45a1-8415-65de5488472f
Kelly, J.J.
ab65aaf7-98c0-4b4f-8956-ce5d2a172dcf
Mythen, M.G.
c82ab585-86d5-44f8-bd3c-ead87c59d459
Sturgess, R.
2a146437-bc8f-4370-a270-6efb600504ed
Calverley, P.M.A.
eea8e7c0-24ae-4e3c-b363-7283864f8914
Kendrick, A.
ab917308-ad10-43b8-bbc1-8e86916545a8
Grocott, M.P.W.
1e87b741-513e-4a22-be13-0f7bb344e8c2
Jack, S.
d824ec2e-e92f-4e68-8fa5-953dfec46208
December 2016
West, M.A.
98b67e58-9875-4133-b236-8a10a0a12c04
Loughney, L.
9c3e7db1-468b-405c-b32f-cedd9cc251fe
Ambler, G.
c4c7c8c3-b1f3-4407-86ee-efe7952d8307
Dimitrov, B.D.
366d715f-ffd9-45a1-8415-65de5488472f
Kelly, J.J.
ab65aaf7-98c0-4b4f-8956-ce5d2a172dcf
Mythen, M.G.
c82ab585-86d5-44f8-bd3c-ead87c59d459
Sturgess, R.
2a146437-bc8f-4370-a270-6efb600504ed
Calverley, P.M.A.
eea8e7c0-24ae-4e3c-b363-7283864f8914
Kendrick, A.
ab917308-ad10-43b8-bbc1-8e86916545a8
Grocott, M.P.W.
1e87b741-513e-4a22-be13-0f7bb344e8c2
Jack, S.
d824ec2e-e92f-4e68-8fa5-953dfec46208
West, M.A., Loughney, L., Ambler, G., Dimitrov, B.D., Kelly, J.J., Mythen, M.G., Sturgess, R., Calverley, P.M.A., Kendrick, A., Grocott, M.P.W. and Jack, S.
(2016)
The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study.
BMC cancer, 16, , [710].
(doi:10.1186/s12885-016-2682-6).
(PMID:27589870)
Abstract
Background: In 2014 approximately 21,200 patients were diagnosed with oesophageal and gastric cancer in England and Wales, of whom 37 % underwent planned curative treatments. Potentially curative surgical resection is associated with significant morbidity and mortality. For operable locally advanced disease, neoadjuvant chemotherapy (NAC) improves survival over surgery alone. However, NAC carries the risk of toxicity and is associated with a decrease in physical fitness, which may in turn influence subsequent clinical outcome. Lower levels of physical fitness are associated with worse outcome following major surgery in general and Upper Gastrointestinal Surgery (UGI) surgery in particular. Cardiopulmonary exercise testing (CPET) provides an objective assessment of physical fitness. The aim of this study is to test the hypothesis that NAC prior to upper gastrointestinal cancer surgery is associated with a decrease in physical fitness and that the magnitude of the change in physical fitness will predict mortality 1 year following surgery.
Methods: This study is a multi-centre, prospective, blinded, observational cohort study of participants with oesophageal and gastric cancer scheduled for neoadjuvant cancer treatment (chemo- and chemoradiotherapy) and surgery. The primary endpoints are physical fitness (oxygen uptake at lactate threshold measured using CPET) and 1-year mortality following surgery; secondary endpoints include post-operative morbidity (Post-Operative Morbidity Survey (POMS)) 5 days after surgery and patient related quality of life (EQ-5D-5 L).
Discussion: The principal benefits of this study, if the underlying hypothesis is correct, will be to facilitate better selection of treatments (e.g. NAC, Surgery) in patients with oesophageal or gastric cancer. It may also be possible to develop new treatments to reduce the effects of neoadjuvant cancer treatment on physical fitness. These results will contribute to the design of a large, multi-centre trial to determine whether an in-hospital exercise-training programme that increases physical fitness leads to improved overall survival.
Text
UGI Study Protocol Paper final r2
- Accepted Manuscript
Text
12885_2016_Article_2682.pdf
- Version of Record
More information
Accepted/In Press date: 5 August 2016
e-pub ahead of print date: 2 September 2016
Published date: December 2016
Organisations:
NIHR Southampton Respiratory Biomedical Research Unit
Identifiers
Local EPrints ID: 403128
URI: http://eprints.soton.ac.uk/id/eprint/403128
ISSN: 1471-2407
PURE UUID: 9490ddee-c5a1-4c3a-8da8-7c3aba0e6663
Catalogue record
Date deposited: 24 Nov 2016 15:20
Last modified: 16 Mar 2024 04:00
Export record
Altmetrics
Contributors
Author:
L. Loughney
Author:
G. Ambler
Author:
B.D. Dimitrov
Author:
J.J. Kelly
Author:
M.G. Mythen
Author:
R. Sturgess
Author:
P.M.A. Calverley
Author:
A. Kendrick
Author:
S. Jack
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics